Bio-Techne Corporation (TECH) — Stock Price, Chart & Analysis
Bio-Techne Corporation (TECH) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $11.38B and a trailing P/E ratio of 62.54. Over the past 52 weeks, TECH has traded between $43.20 and $72.69. Bio-Techne Corporation pays a dividend yielding 0.4%. View the live TECH chart, technical opinion, analyst ratings, fundamentals and latest news below.
Bio-Techne Corporation (TECH) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $11.38B |
| P/E ratio (TTM) | 62.54 |
| EPS (TTM) | $1.16 |
| Dividend yield | 0.4% |
| 52-week high | $72.69 |
| 52-week low | $43.20 |
| Beta | 1.27 |
| Avg. volume | 4.79M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Bio-Techne Corporation (TECH)
How much does one share of Bio-Techne Corporation cost?
As of the latest update, one share of Bio-Techne Corporation (TECH) trades at $100 (+0.00% today).
What is Bio-Techne Corporation's market cap?
Bio-Techne Corporation has a market capitalization of approximately $11.38B.
What is Bio-Techne Corporation's P/E ratio?
Bio-Techne Corporation has a trailing price-to-earnings (P/E) ratio of 62.54.
What is Bio-Techne Corporation's earnings per share (EPS)?
Bio-Techne Corporation's trailing twelve-month EPS is $1.16.
Does Bio-Techne Corporation pay a dividend?
Yes — Bio-Techne Corporation pays a dividend with a yield of 0.4% ($0.32 per share annually).
What is Bio-Techne Corporation's 52-week trading range?
Over the past year, TECH has traded between $43.20 and $72.69.
What is the analyst price target for Bio-Techne Corporation?
The mean analyst price target for Bio-Techne Corporation is $70.73. This is informational only and not investment advice.
Latest Bio-Techne Corporation (TECH) news
- Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer CollaborationNews · Sep 22, 2026
- Bio Techne (TECH) And The Valuation Case Behind Its Recent ReboundNews · Sep 15, 2026
- Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate GoalsNews · Sep 1, 2026
- Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables StocksNews · Aug 31, 2026
- Bio-Techne Corrects Dividend AnnouncementNews · Aug 13, 2026
- Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 SalesNews · Aug 12, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live TECH dashboard…